mylan ripped off the government, ironically by misclassifying epipens as a generic drug /

The US government spent over $1.3 billion on EpiPens from 2011 to 2015. But Mylan,the makers of EpiPen, has been overcharging the government for the life-saving allergy medication by misclassifying it as a generic, and rather than a name brand drug. If you don’t know whether to laugh or bawl at this point,you’re not alone.
Read more...

Source: gawker.com